biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by Sinbobon Mar 08, 2012 10:54am

258 Views

Post# 19643249

weird chart here....

hmmmm....only my opinion but, it sure looks like it is still struggling real hard to stay at this level and not rise. Very low volume....few sellers. Is it a beachball being held down and can't be pushed much lower? Does it want to jump to the surface? That tiny amount of insider selling is uneventful. We will have to wait to see if there is another fiinancing coming...or maybe a cross trade. Whatever, 35 million shares out is very low for a junior with this track record and such potential.

Spring is in the air.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments